Press Releases + News

Date Title and Summary View
Toggle Summary PRO-PHARMACEUTICALS TO PRESENT A CORPORATE UPDATE AT THE RODMAN & RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE View HTML
Toggle Summary Pro-Pharmaceuticals Appoints Arthur R. "Bobby" Greenberg to its Board of Directors View HTML
Toggle Summary Pro-Pharmaceuticals Reports Second Quarter and First Six Months 2009 Financial Results View HTML
Toggle Summary COURT ISSUES JUDGMENT DISMISSING TRADE SECRET LAWSUIT AGAINST PRO-PHARMACEUTICALS View HTML
Toggle Summary PRO-PHARMACEUTICALS PREVAILS IN TRADE SECRET LAWSUIT
Court Dismisses Claims For Lack of Prosecution
View HTML
Toggle Summary PRO-PHARMACEUTICALS NAMES NOTED PHYSICIAN DR. GILBERT S. OMENN TO SCIENTIFIC ADVISORY BOARD
Professor of Internal Medicine, Human Genetics and Public Health at the University of Michigan. Former CEO of the University of Michigan Health System.
View HTML
Toggle Summary PRO-PHARMACEUTICALS CLOSES $500,000 TRANCHE; BRINGS TOTAL TO $3.2 MILLION OF $6.0 MILLION PRIVATE PLACEMENT View HTML
Toggle Summary PRO-PHARMACEUTICALS' CHIEF SCIENTIST PUBLISHED ARTICLES IN THREE PRESTIGIOUS PEER-REVIEWED JOURNALS
NMR Studies Further Define DAVANAT®'s Mechanism of Action with Galectin Receptors Found on Solid Tumors
View HTML
Toggle Summary PRO-PHARMACEUTICALS REPORTS FULL YEAR and FOURTH QUARTER 2008 FINANCIAL RESULTS View HTML
Toggle Summary Pro-Pharmaceuticals Reports First Quarter 2009 Financial Results View HTML